Student’s Name
Institutional Affiliation
Pulmonary embolism is the occlusion of thrombi to the pulmonary artery, typically originating from pelvis and legs large veins. In pulmonary embolism etiology, embolization risk is higher when thrombi proximal are in the calf veins. Thromboemboli can also originate in central veins of the chest or arm veins which can be as a result of thoracic outlet syndromes or caused by central venous catheters (Blann, 2009). Risk factors for pulmonary embolism and deep venous thrombosis are similar both in adults and children. These risk factors include, conditions that cause endothelial dysfunction or injury, conditions impairing venous return including confinement without walking and bed rest. Another risk factor is underlying thrombophilic (hypercoagulable) disorders.
In its pathophysiology, after development of deep venous thrombosis, clots may dislodge and travel through the right side of the heart and the venous system, to be lodge in pulmonary arteries, where they completely or partially occlude one or more vessels. The consequences depend on the number and size of the emboli, the functioning of the right ventricle, lungs underlying conditions and intrinsic thrombolytic ability to dissolve the clot (Blann, 2009). If right ventricle fails, death may occur. Small embolic may begin to lyse immediately and may have no acute physiologic effects and should resolve within days or hours. Large emboli can cause hypoxemia due to perfusion/ventilation (V/Q) mismatch, low mixed venous oxygen content resulting from low cardiac output, a reflex increase in ventilation (tachypnea), atelectasis due to abnormalities in surfactant and alveolar hypocapnia, and increased pulmonary vascular resistance caused by vasoconstriction and mechanical obstruction. Most emboli are reduced by endogenous lysis, with the physiological alterations decreasing within hours or days with some emboli resisting lysis and may persist (Borden, 2009).
Borden, 2009, in 3% to 4% of cases, the chronic obstruction residue leads to chronic thromboembolic pulmonary hypertension that evolve over months to years resulting to chronic heart failure. During large emboli occlusion in major pulmonary arteries, right ventricle pressure increases which can lead to its failure, shock or death. The death risk depends on the rate and degree of rise of right-sided pressures and underlying cardiopulmonary status of the patient. Pulmonary infarction which is often wedge –shaped, Hampton hump and other modalities of imaging occur in 10% of pulmonary embolism patients. The low rate is attributed by the dual blood supply in the lungs. Normally, pulmonary infarction is caused by small emboli that are lodged in many distal pulmonary arteries.
In preventing extensive clot formation, further embolization and new clot formation, initial coagulation which should be followed by maintenance anticoagulation. This therapy should start after pulmonary embolism is suspected (Borden, 2009). Elimination of clots by dissolution with IV or embolectomy or catheter-based thrombolytic therapy should be reflected with patients associated with hyponesion.
References
Blann, A. (2009). Deep vein thrombosis and pulmonary embolism. Keswick: M & K Update.
Bordow, R., Ries, A., & Morris, T. (2005). Manual of clinical problems in pulmonary medicine. Philadelphia: Lippincott Williams & Williams.
The Pathophysiological Etiology and Rationale for a Pulmonary Embolism
Student’s Name
Institutional Affiliation
The Pathophysiological Etiology and Rationale for a Pulmonary Embolism
Pulmonary embolism is the occlusion of thrombi to the pulmonary artery, typically originating from pelvis and legs large veins. In pulmonary embolism etiology, embolization risk is higher when thrombi proximal are in the calf veins. Thromboemboli can also originate in central veins of the chest or arm veins which can be as a result of thoracic outlet syndromes or caused by central venous catheters (Blann, 2009). Risk factors for pulmonary embolism and deep venous thrombosis are similar both in adults and children. These risk factors include, conditions that cause endothelial dysfunction or injury, conditions impairing venous return including confinement without walking and bed rest. Another risk factor is underlying thrombophilic (hypercoagulable) disorders.
In its pathophysiology, after development of deep venous thrombosis, clots may dislodge and travel through the right side of the heart and the venous system, to be lodge in pulmonary arteries, where they completely or partially occlude one or more vessels. The consequences depend on the number and size of the emboli, the functioning of the right ventricle, lungs underlying conditions and intrinsic thrombolytic ability to dissolve the clot (Blann, 2009). If right ventricle fails, death may occur. Small embolic may begin to lyse immediately and may have no acute physiologic effects and should resolve within days or hours. Large emboli can cause hypoxemia due to perfusion/ventilation (V/Q) mismatch, low mixed venous oxygen content resulting from low cardiac output, a reflex increase in ventilation (tachypnea), atelectasis due to abnormalities in surfactant and alveolar hypocapnia, and increased pulmonary vascular resistance caused by vasoconstriction and mechanical obstruction. Most emboli are reduced by endogenous lysis, with the physiological alterations decreasing within hours or days with some emboli resisting lysis and may persist (Borden, 2009).
Borden, 2009, in 3% to 4% of cases, the chronic obstruction residue leads to chronic thromboembolic pulmonary hypertension that evolve over months to years resulting to chronic heart failure. During large emboli occlusion in major pulmonary arteries, right ventricle pressure increases which can lead to its failure, shock or death. The death risk depends on the rate and degree of rise of right-sided pressures and underlying cardiopulmonary status of the patient. Pulmonary infarction which is often wedge –shaped, Hampton hump and other modalities of imaging occur in 10% of pulmonary embolism patients. The low rate is attributed by the dual blood supply in the lungs. Normally, pulmonary infarction is caused by small emboli that are lodged in many distal pulmonary arteries.
In preventing extensive clot formation, further embolization and new clot formation, initial coagulation which should be followed by maintenance anticoagulation. This therapy should start after pulmonary embolism is suspected (Borden, 2009). Elimination of clots by dissolution with IV or embolectomy or catheter-based thrombolytic therapy should be reflected with patients associated with hyponesion.
References
Blann, A. (2009). Deep vein thrombosis and pulmonary embolism. Keswick: M & K Update.
Bordow, R., Ries, A., & Morris, T. (2005). Manual of clinical problems in pulmonary medicine. Philadelphia: Lippincott Williams & Williams.
Delivering a high-quality product at a reasonable price is not enough anymore.
That’s why we have developed 5 beneficial guarantees that will make your experience with our service enjoyable, easy, and safe.
You have to be 100% sure of the quality of your product to give a money-back guarantee. This describes us perfectly. Make sure that this guarantee is totally transparent.
Read moreEach paper is composed from scratch, according to your instructions. It is then checked by our plagiarism-detection software. There is no gap where plagiarism could squeeze in.
Read moreThanks to our free revisions, there is no way for you to be unsatisfied. We will work on your paper until you are completely happy with the result.
Read moreYour email is safe, as we store it according to international data protection rules. Your bank details are secure, as we use only reliable payment systems.
Read moreBy sending us your money, you buy the service we provide. Check out our terms and conditions if you prefer business talks to be laid out in official language.
Read more